Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.
Patients with end-stage renal disease (ESRD) whose creatinine and possibly homocysteine levels in end-stage renal life prolongation is dependent on maintenance dialysis exdisease (ESRD) patients. These findings are in contrast to the well-known association between over-nutrition and poor perience much poorer outcome as compared to the general outcome in the general population. The association between population [1] [2] [3] . Numerous reports indicate that in con- [5], are strongly correlated with increased morbidity and Several possible causes are hypothesized. First, survival bias mortality, including a higher risk of cardiovascular events may play a role since only a small number of patients with chronic kidney disease (CKD) survive long enough to reach and death in dialysis patients ( Fig. 1 ). Similar findings ESRD. Hence, the dialysis patients are probably a distinctively have been reported concerning blood pressure in that selected population out of CKD patients and may not represent low blood pressure, and not hypertension, appears to be the risk factor constellations of their CKD predecessors. Secmore strongly related to poor outcome in dialysis patients ond, the time discrepancy between competitive risk factors may play a role. For example, the survival disadvantages of ( Table 1) . These paradoxic observations have been reunder-nutrition, which is frequently present in dialysis patients, ferred to as "reverse epidemiology" [6, 7] or "risk factor may have a major impact on mortality in a shorter period of paradox" [8] [9] [10] . Such terminologies may not necessarily time, and this overwhelms the long-term negative effects of mean that the principles of vascular pathophysiology are over-nutrition on survival. Third, the presence of the "malnutridifferent in ESRD patients but may indicate that there tion-inflammation complex syndrome" (MICS) in dialysis patients may also explain the existence of reverse epidemiology are other superimposed and more dominant factors that in dialysis patients. Both protein-energy malnutrition and incause apparent reversal of the relationships between risk flammation or the combination of the two are much more factors and outcome. The phenomenon of an established common in dialysis patients than in the general population risk factor in the general population having a markedly and many elements of MICS, such as low weight-for-height, ology in ESRD may help improve the poor outcome in this and other similar but distinct populations.
 2003 by the International Society of Nephrology cept in Asian Americans [22] . BMI predicts mortality risk in dialysis patients independently of serum albumin and recorded clinical assessment of nutritional status. The Diaphane Collaborative Study Group in France was one of the first to report that overall mortality risk decreased with increasing BMI [23] . Notably, however, this was reported for a cohort of younger, mostly nondiabetic, French patients treated with hemodialysis during the 1970s, and adjustment was only made for age and sex. Leavy et al [20] described the predictive value for mortality over 5 years of follow-up of a number of risk factors, recorded at baseline, in a national sample of 3607 hemodialysis patients in the 1990s. In hazard regression models, low BMI was independently and significantly predictive of increased mortality; its independent predictive value of mortality risk persisted even 5 years later. No evidence of increasing mortality risk was found for higher values of BMI. Fleischmann et al [21] analyzed the BMI [26] . *Each the relative risk for dying was reduced by 30% (P Ͻ population has a different follow-up period: 14 years for the general 0.04), and with a one-unit decrease in BMI below 20, population versus 4 years for hemodialysis patients. **BMI stratifications are different in two populations: X-axis is based on the original the relative risk was increased by 1.6-fold (P Ͻ 0.01).
graph of the general population and the original hemodialysis BMI
The longer the patients were on dialysis, the lower were subgroup ranges are printed additionally along the hemodialysis curve.
the BMI values. The greater duration of dialysis vintage with lower BMI might be a cause of the increased mortality, but it is unlikely that slightly higher dialysis vintage with lower BMI could have accounted for such a substan- found that of the three body-size groups, the lowest BMI monly used parameters to quantify changes in body mass group had a 42% higher mortality risk than the highest adjusted for height, and the association between body BMI tertile. Kopple et al [3] evaluated approximately mass and outcome. In some studies of normal adults, a 13,000 hemodialysis patients and showed that those he-J or U curve effect has been observed in which those modialysis patients who had greater weight-for-height individuals with a low BMI also demonstrated an inpercentiles had lower mortality rates. creased mortality, although not as high as obese individu-
ELEMENTS OF REVERSE EPIDEMIOLOGY
The prospective Dialysis Outcomes and Practice Patals [16, 17, 19] .
terns Study (DOPPS) [26, 27] has allowed comparison Hemodialysis patients have lower BMI values as comof BMI-mortality relationships in the United States and pared with age-and sex-matched controls from the gen-Europe and among a variety of "healthier," as compared eral population [1, 3] . A lower BMI is consistently found with "sicker" hemodialysis patient subgroups, such as to be a strong predictor of an elevated mortality risk younger patients, never-smokers, and those with less [20-22] (Fig. 1) . In contrast, a higher BMI, either mild chronic illnesses. The DOPPS study provided baseline to moderate overweight or obesity, has generally not demographic, comorbidity, and BMI data on 9714 hemodialysis patients in the United States and Europe from been associated with any increase in mortality risk, ex- For those with an initial lean body mass Ͼ73%, 63% to creasing BMI. A BMI Ͻ20 kg/m 2 was consistently associated with the highest relative mortality risk. Overall, a 73%, and Ͻ63%, the 2-year survival probabilities were 88.3%, 81.2%, and 65.2%, respectively. Johnson et al [31] lower relative risk (RR) of mortality as compared with a BMI of 23 to 24.9 kg/m 2 , was found for overweight studied the BMI in a limited number of peritoneal dialysis patients and found that obesity conferred a signifi-(BMI 25 to 29.9 kg/m 2 ; RR 0.84; P ϭ 0.008), for mild obesity (BMI 30 to 34.9 kg/m 2 ; RR 0.73; P ϭ 0.0003), cant survival advantage in the peritoneal dialysis population. Chung, Lindholm, and Lee [32] performed a similar and for moderate obesity (BMI 35 to 39.9 kg/m 2 ; RR 0.76; P ϭ 0.02) ( Fig. 2A ). Most intriguingly, subanalysis study in Korean peritoneal dialysis patients and found that lean body mass was an independent predictor of of categories of patients defined by overall health status at the beginning of the study and indicated by severity death in peritoneal dialysis patients.
There are very few studies that have shown a deleteri-of illness tertiles were performed and resulted in similar associations ( Fig. 2B ), contrary to the initial hypothesis ous effect of a high BMI in ESRD patients. These are usually based on small sample sizes or different sub-of the investigators that reverse epidemiology may not exist in healthier or younger ESRD patients. There was groups of dialysis patients. For instance, Kaizu et al [33] studied 116 nondiabetic hemodialysis patients and used a survival benefit for healthy overweight patients (BMI 25 to 29.9 kg/m 2 ) that was even greater for the obese Kaplan-Meier survival analysis and proportional hazard models to calculate the RR of mortality in BMI quintiles. patients (BMI Ն30 kg/m 2 ), and this was observed for the healthier as well as the sicker groups of hemodialysis-They showed that patients with BMI of less than 16.9 kg/m 2 and higher than 23.0 kg/m 2 showed lowered sur-treated patients. Even within a cohort of patients younger than 45 years old with low comorbidity, overweight/obe-vival relative to the patients with BMI of 17.0 to 18.9 kg/m 2 . However, even in this study, patients with a BMI sity was not associated with decreased survival [26, 27] .
Finally, a similar inverse weight-mortality relationship Ͻ16.9 kg/m 2 were shown to have the highest risk of mortality independent of other factors. has been reported among chronic peritoneal dialysis patients. In the CANUSA study, a 1% difference in percent Although high BMI has been emphasized as a strong risk factor for morbidity and mortality in the general lean body mass was associated with a 3% change in the RR of death [28, 29] . McCusker et al [30] found a significantly population, a recent study suggests that a higher BMI in certain age groups in normal or nonuremic individuals may not necessarily be associated with higher morbidity and mortality [11] . Similar to ESRD patients, Grabowski and Ellis [34] showed that a high BMI does not predict mortality in older people. In their Longitudinal Study of Aging that examined 7527 participants 70 years old and older, they demonstrated reduced mortality in obese older people and showed that thin older people remained more likely to die than normal older people. A similar finding from Italy showed that a low BMI was a significant and independent predictor of shortened survival in hospitalized patients [12] .
Blood pressure: Is hypertension protective?
The role of hypertension as a risk factor for increased mulative incidence of cardiovascular events [37] . Similar to the general population, several studies have also suggested that hypertension in dialysis patients is associated with increased mortality risk [38, 39] , including the French its impact on dialysis outcome and on cardiovascular Tassin data on long-duration hemodialysis [40, 41] . This mortality has been underappreciated. Iseki et al [49] has led several advisors to focus on predialysis blood showed a strong association between low diastolic blood pressure (e.g., systolic blood pressure Ͼ160 mm Hg) as pressure and risk of death in a cohort of 1243 hemodialyan indicator of quality of care by hemodialysis units [39] . sis patients who were followed up for 5 years. In this However, although hypertension in ESRD traditionally study, the death rate was inversely correlated with diahas been poorly controlled [42, 43] , elevated blood presstolic blood pressure, which per se showed a significant sure may not represent the primary risk for overall surpositive correlation with serum albumin and a negative vival in dialysis patients [44] [45] [46] . Tassin data showing correlation with age. Zager et al [47] , in a study of more improved dialysis survival with blood pressure control than 5000 hemodialysis patients followed up for a mean [40, 41] may be confounded by other survival advantages of 2.9 years, noted that the relative death rate for patients since the patients treated with 6-hour, three times a week with predialysis or postdialysis hypotension (systolic blood dialysis are reported not to be volume expanded; hence, pressure Ͻ110 mm Hg) increased to four times normal it can be argued that low blood pressure in these individor greater than 2.5 times normal, respectively. Port et al uals is less likely to indicate cardiac pump failure and [51] analyzed data from 4839 hemodialysis patients in more likely to reflect a desirable homodynamic state.
the Case Mix Adequacy Study of the United States Renal Indeed, several recent studies, including those based on Data System (USRDS) and found that when predialysis large sample sizes, failed to find that high blood pressure systolic blood pressure decreased below the reference is an independent mortality risk factor [47, 48] . Findings group (120 to 149 mm Hg), the relative mortality risk presented by Lowrie et al [48] , Duranti, Imperiali, and increased and reached statistically significant values at Sasdelli [44] , Zager et al [47] , and Iseki et al [49] from pressure measurements less than 110 mm Hg ( Fig. 3 ). studies of large hemodialysis populations indicated sur-Fleischmann, Bower, and Salahudeen [8] found that the prisingly little or no risk associated with systolic hypercumulative hazard for dying was significantly influenced tension. In a cross-sectional study of 936 hemodialysis by the predialysis mean arterial pressure tertiles, with the patients in the HEMO Study, Cheung et al [50] reported lowest survival in the lowest third and the best survival in no significant linear or nonlinear association between the upper third. A correlation of low predialysis systolic predialysis systolic blood pressure and any of the cardioblood presssure with increased mortality has also been vascular disease end points.
reported by Lowrie et al [48] and Duranti, Imperiali, While contemporary thinking reiterates the link beand Sasdelli [44] . tween hypertension and cardiovascular morbidity and
The concept of a U-shaped curve linking increased mortality in the general population [35] [36] [37] , recent studmortality to low blood pressure was previously reported ies of ESRD patients point to a link between low blood in a non-ESRD population by Cruickshank, Thorpe, and pressure and poor survival. Even though the adverse consequences of low blood pressure is not a new concept, Zacharias [52] when they examined outcomes in the gen-eral population undergoing antihypertensive treatment. Historically, hypertension is associated with concentric left ventricular hypertrophy (LVH), ventricular dilatation, ischemic heart disease, and congestive heart failure. However, after the development of cardiac failure, low blood pressure or hypotension predicts mortality and is a potential marker for severity of cardiac disease [38, 53] .
In addition, patients presenting with baseline predialysis hypotension may possess such subclinically significant risk factors or comorbidities such as hypoalbuminemia, heart failure, and ischemic cardiomyopathy [49, 54] . Low blood pressure may be a reflection of autonomic neuropathy that, in turn, is a marker for more severe uremic complications. Because antihypertensive drug therapy may contribute to low predialysis systolic blood pressure, [23] reported that a lower plasma total cholesterol between low cholesterol and mortality in older persons level was associated with a significantly higher risk of death in a prospective cohort consisting of 4128 elderly patients from cardiovascular disease in a cohort of 1453 French with a mean age of 78.7 years and a median follow-up hemodialysis patients. Lowrie and Lew [5] analyzed a period of 4.9 years. They found that in those with a low group of more than 12,000 prevalent hemodialysis paserum cholesterol level, defined as Յ160 mg/dL, all-cause tients and found that serum cholesterol level was inmortality was significantly higher than those with normal versely correlated with the risk for death in a multivariate or high serum cholesterol concentrations. Krumholz et al logistic regression adjusting for several case-mix factors
[64] failed to show any significant association between and biochemical parameters ( Fig. 4 ). Avram et al [58] hypercholesterolemia or low HDL-cholesterol and allshowed that serum cholesterol concentration was elecause mortality, coronary heart disease mortality, or hosvated in the long-term dialysis survivors. Fleischmann, pitalization for myocardial infarction or unstable angina Bower, and Salahudeen [8] studied 453 hemodialysis pain a cohort of persons older than 70 years. tients prospectively and showed that among lipids, the second and third tertiles of total cholesterol as well as Serum creatinine: Is high better than low? LDL and HDL cholesterol were associated with better
In the general population, a slight or moderate insurvival, although this was only a trend that was not crease in serum creatinine has been shown to be an indestatistically significant. More recently, Iseki et al [59] pendent risk factor of cardiovascular disease [65] [66] [67] . A reported similar findings based on a sample of 1167 hesecondary analysis of the HOPE Study showed that in modialysis patients who were followed for up to 10 years.
patients who had either preexisting vascular disease or We showed similar findings in a small cohort of hemodidiabetes mellitus and an additional cardiovascular risk alysis patients who were followed for up to 12 months [60]. Of note, some less recent studies in ESRD patients factor, the presence of mild renal insufficiency signifi-cantly increased the risk for subsequent cardiovascular between the fasting plasma tHcys level and the prevalence of cardiovascular disese in dialysis patients, using crude events [65] . The HOT Study showed that a baseline elevation in serum creatinine is powerful predictors of or multiple logistic regression analyses adjusted for other risk factors [80] . More recently Suliman et al [81, 82] cardiovascular events and death [66] .
In dialysis patients, the serum creatinine, a reflection found that among 117 hemodialyis patients, those with cardiovascular disease (60%) had significantly lower tHcys of muscle mass or meat ingestion and/or the degree of dialysis efficiency, has also been shown to be a predictor of levels than those without cardiovascular disease, although both groups still had higher plasma tHcys levels than mortality but in the opposite direction (i.e., those dialysis patients with a higher serum creatinine live longer). This is the general population. Wrone et al [83] performed a crosssectional analysis of 459 dialysis patients, and showed contrary to the notion that well-dialyzed dialysis patients with higher Kt/V should have lower serum creatinine that those with a history of cardiovascular disease had lower levels of predialysis plasma tHcys than those with-concentrations compared to those in whom dialysis treatment is not adequate. Lowrie and Lew [5] found that out a history of cardiovascular disease. This negative relationship persisted in multivariate analyses when control-the serum creatinine level was inversely correlated with the risk for death. Avram et al [58] found that the enroll-ling for predictors of cardiovascular disease, such as age, gender, and BMI. Mean plasma tHcys was higher in ment serum creatinine was significantly higher among long-and very long-term hemodialysis and peritoneal patients without a history of cardiovascular disease than in those with cardiovascular disease [83] . Of note, both survivors. In the study by Tattersall, Greenwood, and Farrington [68] , there was no significant change in the of the above-mentioned studies found a statistically significant, positive correlation between predialysis plasma predialysis serum creatinine values for hemodialysis patients from the time they initiated dialysis as compared tHcys and albumin concentration, which is a known, strong predictor of mortality in dialysis patients. We have with their values 6 months later. These results suggest that the factors that link lower predialysis serum creati-recently found a similar positive correlation in a sample of 368 hemodialysis patients, which may indicate that nine values to increased mortality in dialysis patients may be determined when the patients commence renal replace-plasma tHcys is a nutritional and/or inflammatory marker in dialysis patients (abstract; Kalantar-Zadeh et al, Am ment therapy. In the 1992 USRDS Annual Report, the investigators analyzed hemodialysis patients initiating Soc Nephrol, 13:222A, 2002). It is noteworthy that studies showing the inverse relationship in dialysis patients dialysis in 1986 and 1987 and found that increasing serum creatinine level was associated with decreasing mortality are all of recent origin. One reason why similar results had not been reported in the past may be related to [69]. Fink et al [70] studied 5388 incident hemodialysis patients followed up for almost 2 years and found that publication bias that will be discussed later in this manuscript (see below). serum creatinine level was inversely correlated with mortality risk. Among studies of peritoneal dialysis patients, However, these observations do not necessarily exclude the role of hyperhomocysteinemia as a risk factor a retrospective study of a cohort of 190 peritoneal patients with an average follow-up of 12 months and based for poor ESRD outcome, since other factors might be present that confound the relationship between tHcys on the Cox model found that a low serum creatinine was an independent variable significantly associated with levels and cardiovascular disease. Of particular importance is the fact that even studies that found a reverse increased risk of death [71] . epidemiology confirmed that tHcys was higher in dialysis Plasma homocysteine: Is high better than low?
patients as compared to the general population [82, 83] .
Assuming that an increase in tHcys level carries an inde-Plasma total homocysteine (tHcys) has been established as a new risk factor for increased cardiovascular pendent risk of cardiovascular, this may imply that almost all dialysis patients are already exposed to this morbidity and mortality in the general population [72, 73] . Estimated survival among non-ESRD patients with coro-risk. Thus, the apparently paradoxic association between tHcys and cardiovascular disease does not strictly conflict nary artery disease can be stratified according to plasma total homocysteine levels. Higher homocysteine levels with the thesis that hyperhomocysteinemia is a risk factor for cardiovascular disease. However, within this popula-are associated with a worse outcome [72]. A similar association as in the general population was found in some tion, those with the highest tHcys level may have some survival advantages due to better nutrition. studies of dialysis patients (i.e., a higher plasma tHcys was found to be associated with increased risk of cardio-
Other possible examples of reverse epidemiology vascular disease) [74] [75] [76] [77] [78] [79] .
However, conflicting findings have been reported re-Excess parathyroid hormone (PTH) has long been considered detrimental to the health of patients, including garding the association between the plasma tHcys level and the prevalence of cardiovascular disease in chronic those with ESRD [84] . PTH has been implicated as a multisystem uremic toxin, and hyperparathyroidism can renal failure patients. Bostom et al found no relationship be a debilitating complication in dialysis patients [84] .
homocysteine are established risk factors for ischemic heart disease in the general population. The paradox Hyperphosphatemia that is closely related to hyperparathyroidism is associated with increased mortality in dial-becomes even more paramount when it is recognized that it is not a question of the existence or lack of an ysis patients [85] . Avram et al [86] studied prospectively the relationship between the enrollment serum intact association between these risk factors and the clinical outcomes, but often the complete reversal and indeed PTH and all-cause mortality in 345 hemodialysis and 277 peritoneal dialysis patients for 14 years and found that the opposite direction of this relationship. Hence, there must be prevailing conditions that are characteristically lower than expected levels of PTH in uremic patients are associated with increased mortality. Moreover, Guh present in dialysis patients that render them more susceptible to a poor outcome when low body mass, low et al [87] recently reported similar findings that low levels of serum PTH at entry and lower time-dependent PTH blood pressure, or decreased serum values of cholesterol, creatinine, and homocysteine are present. Several sug-levels predict mortality in hemodialysis patients. Avram et al [86] hypothesized that inadequate protein intake, gested explanations are offered for this inverse association. Survival bias, time discrepancies among competing phosphorus intake or both result in impaired development of the expected secondary hyperparathyroidism risk factors, the MICS, and several other hypotheses are presented as possible causes. and in the excess mortality risk inherent with malnutrition. However, to date epidemiologic studies have shown Survival bias a positive association between a high serum phosphorus and poor outcome among ESRD patients [85, 86] . Hence, Since dialysis patients have undergone specific processes of selection and survival, their characteristics may the association between serum PTH and outcome in dialysis patients may be unrelated to serum phosphorus and not be similar to the general population. Therefore, the relationship between the risk factors and outcomes may may reflect other aspects of nutritional status.
Another example is serum ferritin and its association have been modified. According to an analysis based on the National Health and Nutrition Examination Survey with anemia. In the general population, a low serum ferri- [96] , in the United States there are over 10 to 20 million tin is a marker of iron deficiency and anemia that may patients with chronic kidney disease (CKD) and an elenot respond to erythropoietin unless iron is repleted [88] . vated serum creatinine due to a chronic, irreversible and However, in ESRD patients, a high and not a low serum probably progressive damage to the kidney. However, ferritin is associated with a more severe and refractory according to the USRDS data [1] , the number of people anemia [89, 90] . This may be due to hyporesponsiveness with ESRD is approximately 400,000 at this time and is to erythropoietin, which can occur in the setting of the projected to increase to almost 650,000 by the year 2010.
malnutrition-inflammation complex syndrome (MICS)
This constitutes only a small fraction (less than 5%) of in dialysis patients [60], especially since ferritin is an the large pool of CKD patients in the United States. acute phase reactant [89, 90] .
Current thinking suggests that a large population of CKD Finally, another possible example of risk factor reverpatients will not live long enough to develop ESRD and sal is the association between the amount of energy (calocommence maintenance dialysis. One explanation for rie) or food intake and mortality. In the general populathis phenomenon is that CKD patients have a high mortion, an increased energy intake may be associated with tality rate since many of them have severe and complex increased BMI and hypercholesterolemia and, hence, with comorbid conditions, such as diabetes mellitus, hypera higher mortality rate and risk of cardiovascular disease tension, and atherosclerotic vascular disease. Moreover, [91, 92] . In contrast, in dialysis patients increased protein renal disease with proteinuria or an increased serum creatintake, estimated from the urea generation and urea inine by itself is an independent risk factor for greater kinetics, may lead to an improved nutritional status, remorbidity and mortality, particularly from atheroscleflected by an increased albumin level, and a better surrotic heart and cerebrovascular diseases [65, 66] . Thus, vival [93] [94] [95] . However, data in dialysis patients are many CKD patients do not reach ESRD due to their mostly based on indirect measurements of protein intake high mortality. This can explain why only a small proporand studies concerning the possible association between tion of CKD patients develop ESRD. It is not clear what energy (calorie) intake and dialysis outcomes are yet to specific characteristics of this relatively small percentage be developed. of CKD patients give them a greater survival chance to reach ESRD status. An alternative explanation, how-POSSIBLE EXPLANATIONS FOR ever, is that those CKD patients who develop ESRD REVERSE EPIDEMIOLOGY simply have a more accelerated rate of progression of The concept of reverse epidemiology appears at first their chronic renal failure. But whatever the survival to be confusing, especially because hypertension, obefeatures are, these "unfortunately lucky" individuals may be considered as "specifically selected" people, who are sity, and high levels of serum cholesterol, creatinine, and not necessarily genetically or phenotypically similar to patients have a mortality risk that is greater than the general population [2] , the long-term effects of these risk their CKD predecessors and may not have the survival characteristics and epidemiologic features of their pro-factors on future mortality may be overwhelmed by the short-term effects of other factors on dialysis mortality. genitors. Some of those who have survived to comprise the ESRD population might be "exceptional individu-Indeed, it may be difficult, if not impossible, to observe a significantly greater life expectancy with reduction of als" who successfully survived the conventional (traditional) risk factors, which are often present strongly in the traditional risk factors in dialysis patients who have a short life expectancy, even when such a risk factor CKD patients. Hence, the assumption that the epidemiology of cardiovascular risk factors is the same in ESRD reduction is beneficial in the general population who have a normal life expectancy. individuals as in the general population may be flawed, because a survival bias, a form of selection bias, may An example of this time discrepancy in non-ESRD populations may concern obesity and underweight. In heavily influence the epidemiologic constellations in this small proportion of CKD survivors (i.e., the dialysis pa-the general population in the United States, as well as in most industrialized countries, manifestations of over-tients). A similar trend is observed in elderly individuals, who have reached advanced age possibly due to survival nutrition such as overweight/obesity and hypercholesterolemia are major risk factors for cardiovascular mortality advantages, and they also are reported to have a different epidemiology with different cardiovascular disease risk [15-19, 56, 57] . These are also countries where people have a greater life expectancy compared to individuals factors than the general population [11, 13, 34] .
It should be noted that many epidemiologic studies in in other parts of the world. Studies of risk factors of cardiovascular mortality are essentially based on these ESRD patients are based on a mixed pool of incident and prevalent dialysis patients (i.e., those who have started populations. In contrast, in developing countries, which represent the majority of the world's population, under-dialysis recently and those who have been on dialysis for a number of years are treated equally in such studies).
nutrition is still a powerful determinant of poor clinical outcome and morbidity and mortality, leading to a This may lead to what epidemiologists call "incidenceprevalence" or "survival" bias, which per se is a form of shorter life expectancy [99] [100] [101] . A hypothetical demonstration of the combined effect of competitive risk factors selection bias [97] . In other words, those incident patients who had more risk factors or were more vulnerable to (over-versus under-nutrition) is presented in Figure 5 . Thus, in dialysis patients who have a short life expec-such risks did not survive long enough to be included in a cross-sectional study that encompasses many prevalent tancy, any factor that may improve short-term survival, such as high blood pressure, obesity, and hypercholester-patients who have been on dialysis for a number of years and who hence over-represent ESRD patients who have olemia may exert a desirable effect on longevity, whereas conditions that are traditionally associated with long-exceptional survival advantages. Indeed, the majority of incident dialysis patients die, especially due to the term survival such as rigorous blood pressure control, low body weight-for-height, and low serum cholesterol exceptionally high ESRD mortality rate, currently approximately 20% in the United States [1] . Hence, even and homocysteine, may be less relevant. Such factors may even be harmful if they cause, represent, or aggra-longitudinal studies that are based on a mixture of incident and prevalent dialysis patients may be heavily in-vate states of under-nutrition, hypotension or cardiac failure. fluenced by a survival bias [98] . Survival bias can potentially exert a strong influence on both epidemiologic Malnutrition inflammation complex syndrome (MICS) studies and clinical trials, especially when patients who have varying degrees of duration of dialysis are enrolled Measures of protein-energy malnutrition (PEM) and inflammation are major predictors of clinical outcome together [97, 98] . In this regard, it is possible that the concept of reverse epidemiology is a consequence of in dialysis patients [3-5, 7, 9] . Dialysis patients with cardiovascular disease have a higher prevalence of malnutri-systematic errors in epidemiologic data analysis [83] . However, some epidemiologic data based exclusively on tion and hypoalbuminemia and a lower protein intake than those without cardiovascular disease [7, 102] . Sev-incident dialysis patients still show the same risk factor reversal [25], indicating that this phenomenon cannot be eral studies report strong relationships between hypoalbuminemia and cardiovascular disease in dialysis pa-solely explained by survival bias.
tients and suggest that hypoalbuminemia is an important Time discrepancies among competitive risk factors risk factor for cardiovascular disease in these individuals [54, [103] [104] [105] . Cardiac diseases such as heart failure may Survival advantages that exist in obese, hypertensive, hypercholesterolemic, hypercreatininemic, or hyperho-engender anorexia and, if sufficiently severe, may independently induce muscle wasting, which is also known as mocysteinemic dialysis patients may, in the short-term, outweigh the harmful effects of these risk factors on cardiac cachexia [102, 106] . However, it is not completely clear how cardiac disease, inflammation, hypoalbumi-cardiovascular disease in the long-term. Since dialysis nemia, and other measures of PEM in dialysis patients with reduced renal function or other proinflammatory conditions in dialysis patients. Frequent contact with di-are interrelated [106, 107] . It has been postulated that the common link among these conditions is inflammation alysis membranes, vascular access grafts or catheters or dialysate, or peritoneal dialysis fluid may each constitute [7, 54, 103, 104, 106, 108] . A common mechanism for the development of cardiovascular disease and PEM in a proinflammatory condition [7, 109] . Increased release or activation of inflammatory cytokines, such as interleu-dialysis patients may be cytokine activation associated kin-6 (IL-6) or tumor necrosis factor-␣ (TNF-␣), may shown to be dependent on nutritional status, protein suppress appetite, cause muscle proteolysis and hypointake, and serum albumin in hemodialysis patients. Healbuminemia, and may be involved in the processes that modialysis patients with cardiovascular disease had lower lead to atherosclerosis [66, 104, 110] . Nevertheless, the tHcys levels as well as a higher prevalence of malnutridegree to which PEM in dialysis patients is caused by tion and hypoalbuminemia than those without cardiovasinflammation is not clear [7, 110] . Some studies suggest cular disease. Furthermore, in another study plasma that PEM and inflammation each independently contrib-tHcys was shown to rise during treatment of malnourute to hypoalbuminemia and subsequently increase morished peritoneal dialysis patients with an amino acidbidity and mortality [105] . Since both PEM and inflamcontaining peritoneal dialysate (1.7 g methionine/day) mation are strongly associated with each other and can [115] . The presence of MICS may further reinforce this change many nutritional measures in the same direction, relationship by suppressing serum albumin, which is an and because the relative contributions of measures of important carrier protein for plasma tHcys [81, 82, 106] . these two conditions to each other and to outcomes in The puzzling inverse relationship between a low blood dialysis patients are not yet well defined, MICS has been pressure and poor outcome in the dialysis population suggested to denote the important contribution of both might also be accounted for by nutritional status and/or of these conditions to ESRD outcome [7, 60] . Some inflammation. Iseki et al [49] showed a significant associinvestigators have used other terminologies such as "malation between a low diastolic blood presssure, hypoalbunutrition inflammation atherosclerosis" (MIA) to emminemia, and risk of death in a cohort of hemodialysis phasize the importance of atherosclerosis as the consepatients. They analyzed the causes of death with regard quence of MICS [54, 110] . Furthermore, oxidative stress to the relationship between serum albumin and blood may play an important integral part in the associations pressure in 1243 hemodialysis patients who were folbetween inflammation, malnutrition and atherosclerosis, lowed for up to 5 years. The death rate was inversely since variations of serum albumin may be correlated not correlated with diastolic blood pressure, which per se was only with outcome but also with inflammation, cardiovaspositively correlated with serum albumin and negatively cular disease, and serum cholesterol and tHcys concencorrelated with age. Hence, hypotension may in some trations [111, 112] . No matter what it is called or caused cases be a manifestation of MICS in hemodialysis patients. by, the theory of reverse epidemiology in ESRD is compatible with the existence of MICS or MIA and its inter-Other hypotheses play with the traditional risk factors.
Goldberg, Tindira, and Harter [116] suggest that the The existence of paradoxic risk factors could be accenparadigm of coronary artery disease in ESRD shifts from tuated by the MICS, possibly in several ways. First, pasolely traditional risk factors, such as age, diabetes, hytients who are underweight or who have a low serum perlipidemia, and hypertension, to a number of addicholesterol, creatinine, or homocysteine, may be suffertional factors that may regulate coronary event rates in ing from the MICS and its poor outcome. Thus, MICS a different way in uremia. Theoretically, hypotension may both cause these alterations and also be associated and under-nutrition can contribute to the increased relawith increased mortality either caused by the illnesses tive risk of death by several mechanisms, such as acute that engender the MICS or the cardiovascular disease coronary syndrome, autoregulation dysfunction, ischthat seems to be promoted by the MICS [106, 113, 114] . emia, and arrhythmiagenecity [117, 118] . These factors, Second, the above paradoxic factors may indicate a state if indeed altered or exaggerated in uremic milieu, may of under-nutrition, which may predispose to infection or provide an environment in dialysis patients, in whom other inflammatory processes [7] . Finally, it has been hypotension and undernutrition may become more inargued that when individuals are malnourished, they are fluential than the traditional risk factors in the developmore susceptible to the ravages of inflammatory diseases ment of cardiovascular disese. [113] . Hence, any condition that potentially attenuates Chronic inflammatory processes may independently the magnitude of PEM or inflammation should be favorpredispose to both malnutrition and atherosclerosis. IL-6 able to dialysis patients. This notion can explain why predicts hypocholesterolemia [119] , malnutrition [120, there is a reverse epidemiology of cardiovascular risk 121], and atherosclerosis [122, 123] in dialysis patients. factors in dialysis patients, especially since almost all Inflammation can indeed lead to hypocholesterolemia the so-called nontraditional protective factors, such as in ESRD patients [59, 119] . Moreover, chronic infusion obesity, hypercholesterolemia, hypercreatininemia, and of IL-1 or TNF-␣ (cachectin) has been shown to cause hyperhomocysteinemia, are related to nutritional status. anorexia, rapid weight loss, and a decline in body protein Suliman et al [81, 82] have reported a more specific stores [124] . Hence, given the fact that inflammation is example of the contribution of the MICS to risk factor more common in ESRD patients as compared to the reversal concerning with hyperhomocysteinemia in dialysis patients. In their study, plasma tHcys levels were general population [104, 120], inflammation by itself may precede under-nutrition and lead to the risk factor rever-with inversed association may be to consider them erroneous or flawed and hence be reluctant to report them sals in individuals with ESRD.
There may be other confounding factors that may ex- [131] . However, as more reports indicative of reverse epidemiology in ESRD have been published recently, more plain some of the risk factor reversals in dialysis patients. Both low body mass and low blood pressure may be investigators may be encouraged to report their similar findings. This may explain why more frequent reports consequences of cigarette smoking [125, 126] and/or congestive heart failure [102, 106] , conditions that are associ-and publications consistent with the reverse epidemiology have emerged only recently. ated with increased ESRD mortality. These conditions may also be associated with an increased prevalence of It is important to appreciate that some of the discussed risk factors may represent different biologic or medical inflammation and malnutrition [127, 128] . Heart failure may engender anorexia and may independently induce phenomena in ESRD patients as compared to the general population. Serum creatinine, for instance, is a re-cachexia [106] . A low blood pressure, a potential indicator of severe heart disease, is thus associated with poor flection of renal function in the general population, whereas it is essentially representative of skeletal muscle outcome [53] . Moreover, a low blood pressure may be caused by autonomic neuropathy that, in turn, can be mass and/or meat ingestion as well as the dose of dialysis in ESRD patients. Similarly, a pre-dialysis blood pres-the result of uremic toxicity or the ravages of diabetes [129] . Hence, it may not be normo-or hypotension per sure measurement may represent a different underlying disease processes in hemodialysis patients who are often se that is detrimental but rather the underlying cause of low blood pressure (i.e., cardiac pump failure and/or volume overloaded. Thus, a low predialysis blood pressure in patients who are likely to be volume expanded autonomic neuropathy).
Finally, a less well-substantiated hypothesis represents is more probably due to a sick heart, whereas in the general population it may more likely indicate excellent the notion that what we consider as reverse epidemiology (the stronger impact of under nutrition) may indeed be circulatory homodynamics. Hence, the etiology of "reverse epidemiology" in dialysis patients may be quite the natural epidemiology in human and that the so-called different for various risk factors, and the term "reverse conventional epidemiology (over-nutrition) is a new and epidemiology" may be a misnomer. Nevertheless, it is unusual phenomenon in human history [130] . In recent important to first exhaust the possibility of a single unifydecades, excess weight and obesity have become mass ing entity to be accounted for all or most of the abovephenomena with a pronounced upward trend in most mentioned risk factor reversals. We believe that PEM industrialized nations. However, despite the detrimental and inflammation (MICS) are the best candidates. effects of being overweight, these populations indeed live Despite all these concerns, the evidence is strong that longer than ever. Moreover, with aging, the detrimental a risk factor paradox indeed exits in those who reach effects of obesity, over-nutrition, and hypertension may ESRD and who continue to have an unacceptably high diminish if not disappear, a similar trend that can be rate of mortality, currently approximately 20% in the observed in ESRD population as well.
United States. This high mortality rate has not substantially been changed in the recent years despite aggressive CONCLUSION efforts toward an optimal management of traditional risk The reversal of certain key risk factors in dialysis pafactors in these individuals. Hence, it is important to tients poses serious questions. Is the increasing prevaexplore the causes of reverse epidemiology and to ascerlence of obesity and its detrimental impact to health tain how best to reverse these associations in dialysis in the general population of any relevance in dialysis patients. We believe that in dialysis patients more attenpatients? Do overnutrition, obesity, hypertension, or hytion should be focused on optimal management of underpercholesterolemia that promote atherosclerosis and nutrition and inflammation based on the mechanisms mortality in the general population prevent poor outresponsible for the reverse epidemiology. However, precome in dialysis patients, and if so how? Should dialysis mature or radical conclusions to discontinue antihyperpatients be advised to increase their nutrient intake in tensive or antihyperlipidemic treatment should be avoided order to gain weight and to increase their serum cholesuntil such information is forthcoming. For instance, the terol, creatinine, and homocysteine levels? Should their antihypercholesterolemic agent, 3-hydroxy-3-methylglutarget blood pressure be higher? Can these reversed taryl coenzyme A (HMG-CoA) reductase inhibitor or relationships be used to establish therapeutic goals? such antihypertensive agents as angiotensin-converting Publication bias may have handicapped or delayed enzyme inhibitors may have an anti-inflammatory effect, reporting such paradoxical findings in dialysis patients which can be beneficial in the management of the eleas the association between plasma homocysteine and ments of MICS and improved outcome in dialysis pacardiovascular disease in dialysis patients, since the intients irrespective of the existence of reverse epidemiology [132] [133] [134] [135] . It is also important to appreciate that vestigators' first impression upon encountering results ity in the vulnerable population of ESRD, it is possible 
